AdWiki Webring Site
| SELECT YOUR LANGUAGE:
ar  |
id  |
bg  |
ca  |
ceb  |
cs  |
da  |
de  |
et  |
en  /  /  |
es  |
eo  |
fr  |
gr  |
he  |
hr  |
it  |
ko  |
lt  |
hu  |
nl  |
ja  |
no  |
pl  |
pt  |
ru  |
ro  |
sk  |
sl  |
sr  |
fi  |
sv  |
te  |
tr  |
uk  |
zh 
ATC code L04
From Wikipedia, the free encyclopedia
A section of the Anatomical Therapeutic Chemical Classification System.
L Antineoplastic and immunomodulating agents
[edit] L04A Immunosuppressive agents
[edit] L04AA Selective immunosuppressive agents
- L04AA01 Ciclosporin
- L04AA02 Muromonab-CD3
- L04AA03 Antilymphocyte immunoglobulin (horse)
- L04AA04 Antithymocyte immunoglobulin (rabbit)
- L04AA05 Tacrolimus
- L04AA06 Mycophenolic acid
- L04AA08 Daclizumab
- L04AA09 Basiliximab
- L04AA10 Sirolimus
- L04AA11 Etanercept
- L04AA12 Infliximab
- L04AA13 Leflunomide
- L04AA14 Anakinra
- L04AA15 Alefacept
- L04AA16 Afelimomab
- L04AA17 Adalimumab
- L04AA18 Everolimus
- L04AA19 Gusperimus
- L04AA21 Efalizumab
- L04AA22 Abetimus
- L04AA23 Natalizumab
[edit] L04AX Other immunosuppressive agents
- L04AX01 Azathioprine
- L04AX02 Thalidomide
- L04AX03 Methotrexate
|
Immunomodulators - Immunosuppressants - Immunosuppressive drugs (L04) |
|
| Extracellular |
|
|
CD3 ( Muromonab-CD3, Teplizumab, Visilizumab) · CD4 ( Keliximab, Zanolimumab) · CD11a ( Efalizumab) · CD20 ( Ocrelizumab, Pascolizumab) · CD23 ( Lumiliximab) · IL-2/CD25 ( Basiliximab, Daclizumab, Inolimomab) · CD40 ( Teneliximab) · CD62L/L-selectin ( Aselizumab) · CD147/Basigin ( Gavilimomab, Ziralimumab) · CD154 ( Ruplizumab)
BLyS (Belimumab) · Complement component 5 (Eculizumab) · CTLA-4 (Ipilimumab) · CAT (Metelimumab) · Immunoglobulin E (Omalizumab) · Integrin (Natalizumab) · Interleukin 5 (Mepolizumab) · Interleukin-6 receptor (Tocilizumab) · TNFs (Infliximab, Adalimumab, Certolizumab pegol, Afelimomab, Golimumab) · LFA-1 (Odulimomab)
other monoclonal: Atlizumab, Atorolimumab, Bertilimumab, Cedelizumab, Clenoliximab, Dorlimomab aritox, Dorlixizumab, Elsilimomab, Erlizumab, Faralimomab, Fontolizumab, Galiximab, Gantenerumab, Gomiliximab, Ibalizumab, Lebrilizumab, Lerdelimumab, Maslimomab, Morolimumab, Nerelimomab, Otelixizumab, Pexelizumab, Reslizumab, Rovelizumab, Siplizumab, Talizumab, Telimomab aritox, Toralizumab, Ustekinumab, Vapaliximab, Vepalimomab, Zolimomab aritox
Polyclonal: Anti-thymocyte globulin
|
|
|
|
|
|
|
|
|
|
|
| Intracellular |
|
|
Change language: All |
Arabic |
Indonesian |
Bulgarian |
Catalan |
Cebuano |
Czech |
Danish |
German |
Estonian |
English / / |
Spanish |
Esperanto |
French |
Greek |
Hebrew |
Croatian |
Italian |
Korean |
Lithuanian |
Hungarian |
Flemish / Dutch |
Japanese |
Norwegian |
Polish |
Portugues |
Russian |
Romanian |
Slovakian |
Slovenian |
Serbian |
Suomi / Finish |
Swedish |
Iranian |
Turkish |
Ukrainian |
Chinese
MORE LINKS...
Autorem skryptu AdWiki v0.62 (2007) jest husky83
Licencję na skrypt dla strony DAWAJ.INFO posiada dzankes
Wikipedia® jest zarejestrowanym znakiem towarowym Wikimedia Foundation |
